CLARENCE, N.Y.--(BUSINESS WIRE)--Greatbatch, Inc. (NYSE: GB) announced today that it is has signed a definitive agreement to acquire Precimed, a leading technology-driven supplier to the orthopedic industry. This agreement also includes Precimed’s contract to acquire the operations of another company in the orthopedic industry. The combined transaction will establish Greatbatch as one of the top three suppliers to Orthopedic OEMs. This transaction significantly diversifies Greatbatch’s market presence into the orthopedic market and establishes the company as a leading OEM supplier to multiple market verticals, including the Cardiac Rhythm Management, Vascular, Neurostimulation and Specialty Commercial Power markets. Under terms of the agreement, the aggregate purchase price will be approximately $125 million depending on closing adjustments.
